Adriano Rodríguez Trujillo

Adriano Rodríguez Trujillo

Auto-generated profile, based on publicly available information

Adriano Rodríguez Trujillo

Gynecology Oncology Section, Department of Gynecology, Hospital Clìnic, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2018 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
ARAdriano Rodríguez‐Trujillo
Adriano Rodríguez‐Trujillo
PFPere Fuste
Pere Fuste
PPPilar Paredes
Pilar Paredes
EMEduard Mension
Eduard Mension
NANúria Agustí
Núria Agustí
ATAureli Torné
Aureli Torné

20 July 2018 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
ARAdriano Rodríguez-Trujillo
Adriano Rodríguez-Trujillo
CMCristina Martí
Cristina Martí
MAMartina Aida Angeles
Martina Aida Angeles
ASAdriana Sierra
Adriana Sierra
RERoser Esteve
Roser Esteve
MPMarta del Pino
Marta del Pino
To assess the prognostic value of human papillomavirus (HPV) 16/18 genotyping and p16/Ki-67 dual staining cytology in high-risk HPV (hrHPV)-positive women with no lesion or minor abnormalities. We evaluated progression to high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grades 2 to 3 or cervical cancer (HSIL/CIN2+), persistence/regression of hrHPV infection in women referred to colposcopy showing hrHPV infection, histology diagnosis different from HSIL/CIN2+, and negative cytology. HPV 16/18 genotyping and dual staining were performed in liquid-based cytologic specimens obtained on the first visit. Progression was observed in 16 (8.0%) of 200 women. Those with HPV 16/18 infection had an increased risk of progression compared with women infected by other hrHPV types, and they also showed more persistence. However, no association was observed between progression or persistence and the result of the dual staining. HPV 16/18-positive women with no lesions or minor abnormalities are at high risk of progression to HSIL/CIN2+ and hrHPV persistence.

27 December 2018 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Closed access
PDF file
ATAdriano Rodríguez Trujillo
Adriano Rodríguez Trujillo